Advertisement

The Nutshell

» cancer and cell & molecular biology

Daily News Roundup

Most Recent

image: Legislating Negative Result Reporting

Legislating Negative Result Reporting

By | May 7, 2012

A new bill aims to increase transparency in cancer clinical trials by requiring researchers to divulge all outcomes.

2 Comments

image: Nervous Mice Get Worse Cancer

Nervous Mice Get Worse Cancer

By | May 3, 2012

Anxious mice are more likely to come down with aggressive skin cancer than those who show less stress on behavioral tests.

0 Comments

image: Building a Better Sheep

Building a Better Sheep

By | April 25, 2012

Chinese scientists claim to have cloned a lamb carrying a roundworm gene that aids in the production of polyunsaturated fatty acids.

6 Comments

image: Stem Cell Researcher Fabricates Data

Stem Cell Researcher Fabricates Data

By | April 16, 2012

A scientist who claimed to have injected monkey embryonic stem cells into the eyes of rats to improve their vision accepts the penalty for research misconduct.

8 Comments

image: Huntington's Disease Protects from Cancer?

Huntington's Disease Protects from Cancer?

By | April 13, 2012

Swedish researchers have discovered that patients with the neurodegenerative disorder had half the normal expected risk of developing tumors.

6 Comments

image: Identifying Diet-Treatable Diseases

Identifying Diet-Treatable Diseases

By | April 10, 2012

Scientists test which mutations underlie metabolic diseases that may benefit from changes in diet.

6 Comments

image: A Universal Cancer Vaccine?

A Universal Cancer Vaccine?

By | April 10, 2012

A vaccine that targets 90 percent of all cancers shows promise in early clinical trials.

0 Comments

image: Tall Women Beware

Tall Women Beware

By | April 5, 2012

Extra inches may mean a higher chance of getting ovarian cancer.

0 Comments

image: How Predictive are Genomes?

How Predictive are Genomes?

By | April 3, 2012

Researchers put the predictive power of whole genome sequencing to the test.

2 Comments

image: Failed Drugs Expose Preclinical Blunders

Failed Drugs Expose Preclinical Blunders

By | March 30, 2012

Once a promising cancer treatment, the failure of PARP inhibitors in the clinic may be due to flawed preclinical studies.

2 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
Advertisement
Molecular Devices
Molecular Devices
Life Technologies